2-169256524-G-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_004525.3(LRP2):​c.2640-288C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.923 in 152,178 control chromosomes in the GnomAD database, including 64,978 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.92 ( 64978 hom., cov: 32)

Consequence

LRP2
NM_004525.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.666

Publications

8 publications found
Variant links:
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
LRP2 Gene-Disease associations (from GenCC):
  • Donnai-Barrow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Stickler syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 2-169256524-G-T is Benign according to our data. Variant chr2-169256524-G-T is described in ClinVar as Benign. ClinVar VariationId is 1246474.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.976 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004525.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP2
NM_004525.3
MANE Select
c.2640-288C>A
intron
N/ANP_004516.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP2
ENST00000649046.1
MANE Select
c.2640-288C>A
intron
N/AENSP00000496870.1
LRP2
ENST00000443831.1
TSL:2
c.2229-288C>A
intron
N/AENSP00000409813.1

Frequencies

GnomAD3 genomes
AF:
0.923
AC:
140296
AN:
152060
Hom.:
64919
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.979
Gnomad AMI
AF:
0.859
Gnomad AMR
AF:
0.928
Gnomad ASJ
AF:
0.823
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.913
Gnomad FIN
AF:
0.907
Gnomad MID
AF:
0.901
Gnomad NFE
AF:
0.891
Gnomad OTH
AF:
0.909
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.923
AC:
140412
AN:
152178
Hom.:
64978
Cov.:
32
AF XY:
0.924
AC XY:
68763
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.979
AC:
40672
AN:
41540
American (AMR)
AF:
0.928
AC:
14179
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.823
AC:
2855
AN:
3470
East Asian (EAS)
AF:
0.999
AC:
5165
AN:
5170
South Asian (SAS)
AF:
0.913
AC:
4404
AN:
4826
European-Finnish (FIN)
AF:
0.907
AC:
9609
AN:
10596
Middle Eastern (MID)
AF:
0.901
AC:
263
AN:
292
European-Non Finnish (NFE)
AF:
0.891
AC:
60562
AN:
67988
Other (OTH)
AF:
0.909
AC:
1920
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
547
1094
1642
2189
2736
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
908
1816
2724
3632
4540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.896
Hom.:
52957
Bravo
AF:
0.928
Asia WGS
AF:
0.964
AC:
3344
AN:
3468

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.21
DANN
Benign
0.56
PhyloP100
-0.67
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs830958; hg19: chr2-170113034; API